|
FDA Called on to Define ‘Life-Supporting’ Drug in Shortage Notification Mandates
Pharma stakeholders are calling on the FDA to publish a list of critical drugs to help clarify what products fall under current requirements and possible future laws for drug shortage notification.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives